Upcoming Meetings: FDA Orthopedic and Rehabilitation Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA Orthopedic and Rehabilitation Devices Panel: Scheduled to meet Nov. 20-21 at Hilton Hotel in Gaithersburg, Maryland to discuss two premarket approval applications for use of sodium hyaluronate-based products indicated for pain reduction and/or joint dysfunction in arthritic knees. One of the PMAs is for Biomatrix' Synvisc, which is sold in Canada and Europe. Open committee discussion is scheduled for the afternoon of Nov. 20 and the morning of Nov. 21...